KUALA LUMPUR: Pharmaceutical stocks are in the spotlight in early trade Wednesday, dominating the gainers’ list on Bursa Malaysia.
Pharmaceutical companies across the world have been working on developing a Covid-19 vaccine.
Pharmaniaga, the top gainer on Bursa Malaysia surged 99 sen to RM4.49, its highest since December 2017.
Last week, Science, Technology and Innovation Minister Khairy Jamaluddin said that Pharmaniaga and Duopharma would undertake the fill and finish processes for the Covid-19 vaccine, once it is developed.
Khairy said Prime Minister Tan Sri Muhyiddin Yassin had agreed for the facilities of the two companies to be utilised for the purpose, noting that the main challenge for the production of the vaccine was the finishing process.
"We will be purchasing the vaccine overseas, either from China, the US or the UK, in bulk, and we will be doing the bottling process here," Khairy said.
Did you find this article insightful?
100% readers found this article insightful